Literature DB >> 19280174

[Metastatic malignant choroidal melanoma: a case report about 18 years with palliative operative treatment].

T Prietzel1, I Haferkorn, A Macher, E Schumann, G von Salis-Soglio, T Aigner.   

Abstract

Bone metastases are found in 29% of patients with metastatic malignant choroidal melanoma, which is associated with poor prognosis. However there are several reports about prolonged survival. The unusual case of a patient is described, who suffered from a melanoma with orbital invasion and survived more than 18 years. Metastases were found 12 years after initial therapy. Three palliative operations made a survival of further 7 years with high quality of life possible. Therefore moderately palliative operations are recommended in case of metastatic malignant choroidal melanoma.

Entities:  

Mesh:

Year:  2009        PMID: 19280174     DOI: 10.1007/s00132-009-1409-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  10 in total

1.  Variates of survival in metastatic uveal melanoma.

Authors:  Petra Rietschel; Katherine S Panageas; Christine Hanlon; Ami Patel; David H Abramson; Paul B Chapman
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

2.  Heterogeneous survival rates for isolated skeletal metastases from melanoma.

Authors:  D K DeBoer; H S Schwartz; S Thelman; V H Reynolds
Journal:  Clin Orthop Relat Res       Date:  1996-02       Impact factor: 4.176

Review 3.  [Metastatic uveal melanoma. Development of neoadjuvant treatment in animal experiments].

Authors:  S Dithmar; A W Adams; D Rusciano; H E Grossniklaus
Journal:  Ophthalmologe       Date:  2001-08       Impact factor: 1.059

4.  Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.

Authors:  S Eskelin; S Pyrhönen; P Summanen; M Hahka-Kemppinen; T Kivelä
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

5.  Surgical therapy for distant metastases of malignant melanoma.

Authors:  T Meyer; S Merkel; J Goehl; W Hohenberger
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

6.  Protracted survival after resection of metastatic uveal melanoma.

Authors:  T Aoyama; M J Mastrangelo; D Berd; F E Nathan; C L Shields; J A Shields; E L Rosato; F E Rosato; T Sato
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

7.  Survival of patients with metastases from uveal melanoma.

Authors:  E S Gragoudas; K M Egan; J M Seddon; R J Glynn; S M Walsh; S M Finn; J E Munzenrider; M D Spar
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

8.  Prognosis and treatment of disseminated uveal melanoma.

Authors:  R Kath; J Hayungs; N Bornfeld; W Sauerwein; K Höffken; S Seeber
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

9.  Skeletal metastases of melanoma.

Authors:  W R Stewart; R H Gelberman; J M Harrelson; H F Seigler
Journal:  J Bone Joint Surg Am       Date:  1978-07       Impact factor: 5.284

10.  Prolonged survival after complete resection of metastases from intraocular melanoma.

Authors:  Eddy C Hsueh; Richard Essner; Leland J Foshag; Xing Ye; He-Jing Wang; Donald L Morton
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.